Lexapro News
Most Popular Lexapro Story
Don't look for Lundbeck earnings growth until 2015
You can't accuse Lundbeck CEO Ulf Wiinberg of misdirection. In announcing the Danish drugmaker's latest results, Wiinberg flat-out stated that profits won't be rising anytime soon. "Growth in Read more...
Latest Headlines
- February 8, 2012
- December 7, 2011
- October 24, 2011
- October 18, 2011
- August 15, 2011
- April 26, 2011
- January 19, 2011
- November 2, 2010
- September 17, 2010
- April 5, 2010
- September 2, 2009
- March 23, 2009
- February 26, 2009
- January 29, 2009
- January 21, 2009
- January 18, 2008
- January 15, 2008
- September 6, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
